DD209967A5 - Verfahren zur herstellung von an der haut befestigbaren, insbesondere muskelkrampfloesenden praeparaten - Google Patents

Verfahren zur herstellung von an der haut befestigbaren, insbesondere muskelkrampfloesenden praeparaten Download PDF

Info

Publication number: DD209967A5
Authority: DD; German Democratic Republic
Prior art keywords: substances; item; trace elements; skin; support surface
Prior art date: 1982-07-16

Application number

DD83252992A

Other languages

German (de)

English (en)

Inventor

Otto Mallasz

Original Assignee

Central Wechsel Creditbank

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-07-16

Filing date

1983-07-12

Publication date

1984-05-30

1983-07-12 Application filed by Central Wechsel Creditbank filed Critical Central Wechsel Creditbank

1984-05-30 Publication of DD209967A5 publication Critical patent/DD209967A5/de

Links

239000000853 adhesive Substances 0.000 title claims abstract description 5
238000004519 manufacturing process Methods 0.000 title 1
238000002360 preparation method Methods 0.000 claims abstract description 30
239000000126 substance Substances 0.000 claims abstract description 27
238000000034 method Methods 0.000 claims abstract description 23
239000007769 metal material Substances 0.000 claims abstract description 22
239000011573 trace mineral Substances 0.000 claims abstract description 22
235000013619 trace mineral Nutrition 0.000 claims abstract description 22
239000003814 drug Substances 0.000 claims abstract description 12
239000007788 liquid Substances 0.000 claims abstract description 11
239000002253 acid Substances 0.000 claims abstract description 6
230000001070 adhesive effect Effects 0.000 claims abstract description 4
239000011241 protective layer Substances 0.000 claims abstract description 4
239000007787 solid Substances 0.000 claims abstract description 3
201000004624 Dermatitis Diseases 0.000 claims description 14
229910052751 metal Inorganic materials 0.000 claims description 14
239000002184 metal Substances 0.000 claims description 14
239000004480 active ingredient Substances 0.000 claims description 12
229940079593 drug Drugs 0.000 claims description 8
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
239000010949 copper Substances 0.000 claims description 6
239000011505 plaster Substances 0.000 claims description 6
RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 claims description 4
239000000843 powder Substances 0.000 claims description 4
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
239000000956 alloy Substances 0.000 claims description 3
229910045601 alloy Inorganic materials 0.000 claims description 3
229910017052 cobalt Inorganic materials 0.000 claims description 3
239000010941 cobalt Substances 0.000 claims description 3
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 3
229910052802 copper Inorganic materials 0.000 claims description 3
239000011630 iodine Substances 0.000 claims description 3
229910052740 iodine Inorganic materials 0.000 claims description 3
229910052742 iron Inorganic materials 0.000 claims description 3
WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 3
229910052717 sulfur Inorganic materials 0.000 claims description 3
239000011593 sulfur Substances 0.000 claims description 3
239000011701 zinc Substances 0.000 claims description 3
229910052725 zinc Inorganic materials 0.000 claims description 3
ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 2
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 2
229910052785 arsenic Inorganic materials 0.000 claims description 2
RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims description 2
229910052797 bismuth Inorganic materials 0.000 claims description 2
JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 2
239000000835 fiber Substances 0.000 claims description 2
229910052750 molybdenum Inorganic materials 0.000 claims description 2
239000011733 molybdenum Substances 0.000 claims description 2
239000010970 precious metal Substances 0.000 claims description 2
229910052705 radium Inorganic materials 0.000 claims description 2
HCWPIIXVSYCSAN-UHFFFAOYSA-N radium atom Chemical compound [Ra] HCWPIIXVSYCSAN-UHFFFAOYSA-N 0.000 claims description 2
239000010802 sludge Substances 0.000 claims description 2
239000011135 tin Substances 0.000 claims description 2
229910052718 tin Inorganic materials 0.000 claims description 2
UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims 1
229910002091 carbon monoxide Inorganic materials 0.000 claims 1
239000008187 granular material Substances 0.000 claims 1
230000007935 neutral effect Effects 0.000 claims 1
231100000252 nontoxic Toxicity 0.000 claims 1
230000003000 nontoxic effect Effects 0.000 claims 1
-1 sulfur ions Chemical class 0.000 claims 1
230000000694 effects Effects 0.000 abstract description 21
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
201000010099 disease Diseases 0.000 abstract description 9
239000000463 material Substances 0.000 abstract description 2
239000013543 active substance Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
239000003179 convulsant agent Substances 0.000 abstract 1
239000004744 fabric Substances 0.000 abstract 1
238000001467 acupuncture Methods 0.000 description 14
208000007101 Muscle Cramp Diseases 0.000 description 12
210000004243 sweat Anatomy 0.000 description 9
208000005392 Spasm Diseases 0.000 description 8
210000003205 muscle Anatomy 0.000 description 8
208000002193 Pain Diseases 0.000 description 7
230000007812 deficiency Effects 0.000 description 6
201000008482 osteoarthritis Diseases 0.000 description 5
238000011282 treatment Methods 0.000 description 5
239000011782 vitamin Substances 0.000 description 5
235000013343 vitamin Nutrition 0.000 description 5
229940088594 vitamin Drugs 0.000 description 5
229930003231 vitamin Natural products 0.000 description 5
210000004027 cell Anatomy 0.000 description 4
239000003792 electrolyte Substances 0.000 description 4
150000002500 ions Chemical class 0.000 description 4
208000008035 Back Pain Diseases 0.000 description 3
208000008930 Low Back Pain Diseases 0.000 description 3
230000001773 anti-convulsant effect Effects 0.000 description 3
238000002474 experimental method Methods 0.000 description 3
235000011389 fruit/vegetable juice Nutrition 0.000 description 3
210000005036 nerve Anatomy 0.000 description 3
239000002245 particle Substances 0.000 description 3
206010010904 Convulsion Diseases 0.000 description 2
208000007353 Hip Osteoarthritis Diseases 0.000 description 2
206010034464 Periarthritis Diseases 0.000 description 2
208000008765 Sciatica Diseases 0.000 description 2
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
208000004760 Tenosynovitis Diseases 0.000 description 2
210000000941 bile Anatomy 0.000 description 2
230000031018 biological processes and functions Effects 0.000 description 2
210000002421 cell wall Anatomy 0.000 description 2
229910052729 chemical element Inorganic materials 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
239000000812 cholinergic antagonist Substances 0.000 description 2
238000003745 diagnosis Methods 0.000 description 2
238000009792 diffusion process Methods 0.000 description 2
230000035876 healing Effects 0.000 description 2
206010022437 insomnia Diseases 0.000 description 2
238000011835 investigation Methods 0.000 description 2
150000002739 metals Chemical class 0.000 description 2
239000000203 mixture Substances 0.000 description 2
230000003204 osmotic effect Effects 0.000 description 2
239000011148 porous material Substances 0.000 description 2
230000001681 protective effect Effects 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
206010039722 scoliosis Diseases 0.000 description 2
229910052711 selenium Inorganic materials 0.000 description 2
239000011669 selenium Substances 0.000 description 2
239000000243 solution Substances 0.000 description 2
230000008961 swelling Effects 0.000 description 2
206010000087 Abdominal pain upper Diseases 0.000 description 1
208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
208000034656 Contusions Diseases 0.000 description 1
208000027219 Deficiency disease Diseases 0.000 description 1
206010013935 Dysmenorrhoea Diseases 0.000 description 1
208000004929 Facial Paralysis Diseases 0.000 description 1
206010017999 Gastrointestinal pain Diseases 0.000 description 1
206010019233 Headaches Diseases 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
206010049949 Intercostal neuralgia Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
208000019695 Migraine disease Diseases 0.000 description 1
208000000112 Myalgia Diseases 0.000 description 1
208000003251 Pruritus Diseases 0.000 description 1
208000025747 Rheumatic disease Diseases 0.000 description 1
201000001880 Sexual dysfunction Diseases 0.000 description 1
206010041591 Spinal osteoarthritis Diseases 0.000 description 1
208000009205 Tinnitus Diseases 0.000 description 1
206010044074 Torticollis Diseases 0.000 description 1
208000036826 VIIth nerve paralysis Diseases 0.000 description 1
241000607479 Yersinia pestis Species 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
238000004026 adhesive bonding Methods 0.000 description 1
230000007815 allergy Effects 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
210000003423 ankle Anatomy 0.000 description 1
230000002921 anti-spasmodic effect Effects 0.000 description 1
239000001961 anticonvulsive agent Substances 0.000 description 1
229960003965 antiepileptics Drugs 0.000 description 1
208000006673 asthma Diseases 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
230000007177 brain activity Effects 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
238000001311 chemical methods and process Methods 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000009519 contusion Effects 0.000 description 1
230000036461 convulsion Effects 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
208000002173 dizziness Diseases 0.000 description 1
229940088679 drug related substance Drugs 0.000 description 1
230000005611 electricity Effects 0.000 description 1
230000005518 electrochemistry Effects 0.000 description 1
238000005868 electrolysis reaction Methods 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000012530 fluid Substances 0.000 description 1
239000011888 foil Substances 0.000 description 1
210000000232 gallbladder Anatomy 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
231100000869 headache Toxicity 0.000 description 1
239000005556 hormone Substances 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
208000018197 inherited torticollis Diseases 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
230000000968 intestinal effect Effects 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
230000001788 irregular Effects 0.000 description 1
230000007803 itching Effects 0.000 description 1
239000010410 layer Substances 0.000 description 1
239000007937 lozenge Substances 0.000 description 1
230000003340 mental effect Effects 0.000 description 1
208000030159 metabolic disease Diseases 0.000 description 1
206010027599 migraine Diseases 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
239000011707 mineral Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
230000003387 muscular Effects 0.000 description 1
208000010125 myocardial infarction Diseases 0.000 description 1
230000008035 nerve activity Effects 0.000 description 1
229910000510 noble metal Inorganic materials 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
230000000149 penetrating effect Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
208000001297 phlebitis Diseases 0.000 description 1
238000010248 power generation Methods 0.000 description 1
230000002265 prevention Effects 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
208000020016 psychiatric disease Diseases 0.000 description 1
230000000552 rheumatic effect Effects 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
231100000872 sexual dysfunction Toxicity 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
210000002460 smooth muscle Anatomy 0.000 description 1
230000002048 spasmolytic effect Effects 0.000 description 1
208000005801 spondylosis Diseases 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
230000035900 sweating Effects 0.000 description 1
201000004415 tendinitis Diseases 0.000 description 1
238000012360 testing method Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
210000003813 thumb Anatomy 0.000 description 1
231100000886 tinnitus Toxicity 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
208000004371 toothache Diseases 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
231100000167 toxic agent Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
206010044652 trigeminal neuralgia Diseases 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00919—Plasters containing means for physical therapy, e.g. cold or magnetic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00919—Plasters containing means for physical therapy, e.g. cold or magnetic
- A61F2013/00923—Plasters containing means for physical therapy, e.g. cold or magnetic triboelectricity

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Testing And Monitoring For Control Systems (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DD83252992A 1982-07-16 1983-07-12 Verfahren zur herstellung von an der haut befestigbaren, insbesondere muskelkrampfloesenden praeparaten DD209967A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU822195A HU184575B (en)	1982-07-16	1982-07-16	Method for producing preparations fixable on skin generating locally electrolytic and bio currents

Publications (1)

Publication Number	Publication Date
DD209967A5 true DD209967A5 (de)	1984-05-30

Family

ID=10958788

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD83252992A DD209967A5 (de)	1982-07-16	1983-07-12	Verfahren zur herstellung von an der haut befestigbaren, insbesondere muskelkrampfloesenden praeparaten

Country Status (23)

Country	Link
US (1)	US4755384A (fr)
JP (1)	JPH0811733B2 (fr)
AU (1)	AU565141B2 (fr)
BE (1)	BE897292A (fr)
CA (1)	CA1228540A (fr)
CH (1)	CH664896A5 (fr)
DD (1)	DD209967A5 (fr)
DE (2)	DE3390091C1 (fr)
DK (1)	DK163106C (fr)
ES (1)	ES524139A0 (fr)
FI (1)	FI84430C (fr)
FR (1)	FR2531862B1 (fr)
GB (1)	GB2133287B (fr)
HK (1)	HK44488A (fr)
HU (1)	HU184575B (fr)
IL (1)	IL69179A (fr)
IT (1)	IT1193431B (fr)
NL (1)	NL8320207A (fr)
PL (1)	PL145842B1 (fr)
SE (1)	SE462198B (fr)
SG (1)	SG12888G (fr)
SU (1)	SU1489574A3 (fr)
WO (1)	WO1984000298A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3729443A1 (de) *	1987-09-03	1989-03-16	Riess Ortrun	Quaddelsetzpflaster

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5364628A (en) *	1985-05-31	1994-11-15	Sandoz Ltd.	Pharmaceutical compositions
JPH01502428A (ja) *	1986-03-11	1989-08-24	ファービアーン，カーロリュ	化粧品組成物およびその製造方法
JPS6468316A (en) *	1987-09-08	1989-03-14	Teikoku Seiyaku Kk	External plaster containing salbutamol
DE3929411A1 (de) *	1988-09-22	1990-03-29	Siegfried Natterer	Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung
DE69009540T2 (de) *	1989-03-15	1994-09-29	Nitto Denko Corp	Arzneimittel enthaltendes Heftpflaster.
DE4242040A1 (de) *	1992-12-12	1994-06-16	Hauser Willy E	Beschichteter Träger zur Diagnose und Therapie von Erkrankungen sowie Verwendung des Trägers
GB9320407D0 (en) *	1993-10-04	1993-11-24	Large Allan V	Rheum-ease transdermal copper patch
FR2731620B1 (fr) *	1995-03-13	1997-06-06	Drouault Guy	Compositions pharmaceutiques pour la regulation de la polarisation des muscles lisses unitaires
GB2307862A (en) *	1995-12-05	1997-06-11	David Jehan	Patch structures for transdermal therapy
JP2001513803A (ja) *	1997-03-03	2001-09-04	ラボラトワールルミレア	植物抽出物組成物、その製造方法、及びそれを含む医薬組成物
IT1295067B1 (it) *	1997-09-25	1999-04-27	Walter Tarello	Uso di arsenico per preparare un medicamento per il trattamento della sindrome premestruale
US6387973B1 (en)	1999-08-12	2002-05-14	Kay Metzeler Limited	Flexible polyurethane foam containing copper
IL134269A (en) *	2000-01-27	2006-06-11	L R Res & Dev Ltd	Anti-inflammatory bandage
PL2257254T3 (pl) *	2008-02-28	2012-09-28	Steffen Barth	Plaster
EP2505680B1 (fr)	2011-03-30	2015-05-06	MEDIKA S.r.l.	Alliage métallique de cuivre
CN105828810B (zh)	2013-12-17	2020-03-17	玫琳凯有限公司	来自植物材料的活性成分向皮肤的递送
USD1108590S1 (en) *	2023-09-06	2026-01-06	Advanced Drainage Systems, Inc.	Reducing flat top drainage structure

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE88247C (fr) *
FR740767A (fr) *	1932-06-11	1933-02-01		Procédé pour la fabrication d'un emplâtre curatif pour blessures
GB415213A (en) *	1933-05-01	1934-08-23	Paul Pick	Improved sterile and self-sterilizing cellulosic fibrous products
US2111912A (en) *	1935-10-19	1938-03-22	Govett Thomas	Colloidal gold-containing cream
DE807123C (de) *	1948-10-02	1951-06-25	Julius Lindenmeyer Dr Ing	Verbandstoff
DE875707C (de) *	1950-02-11	1953-05-04	Helmut Dr Phil Knauer	Folie zu therapeutischen Zwecken in Form von Binden, Bandagen, Pflastern, Schuheinlegesohlen u. dgl. und Verfahren zu ihrer Herstellung
DE871823C (de) *	1951-05-23	1953-03-26	Heinrich Dr-Ing Messer	Verfahren zur Herstellung desinfizierender und heilender Verbandstoffe
GB762956A (en) *	1952-08-20	1956-12-05	Jacques Werman	An iodine carrier
DE1798343U (de) *	1959-04-27	1959-10-22	Willy Dr Med Seuss	Verband, wie binde oder mit klebstoff versehenes pflaster.
US3046188A (en) *	1959-07-27	1962-07-24	Gaudian Bernhard	Fungicidal composition
US3326213A (en) *	1964-07-09	1967-06-20	John P Gallagher	Therapeutic dressing material and method of using the same
US3464413A (en) *	1967-05-26	1969-09-02	United Merchants & Mfg	Medical bandages
US3639575A (en) *	1968-06-19	1972-02-01	Basf Wyandotte Corp	Silver ion gel compositions and method of using the same
US3598123A (en) *	1969-04-01	1971-08-10	Alza Corp	Bandage for administering drugs
DE1929722A1 (de) *	1969-06-11	1970-12-17	Georg Hubmann	Moorkompresse,insbesondere fuer Herztherapie
FR2158139A1 (en) *	1971-11-05	1973-06-15	Sotil Marie	Biological liquids suitable for application to skin - contg gold particles in suspension
US4340590A (en) *	1977-08-02	1982-07-20	Lundy Research Laboratories, Inc.	Method for reducing or inhibiting ecchymosis in skin tissues with inorganic selenium compositions
DE2828936C2 (de) *	1978-06-30	1982-06-24	Frank D. Restan Va. Ellrich	Band zur therapeutischen Behandlung
FR2465483A1 (fr) *	1978-11-08	1981-03-27	Ruchonnet Georges	Alliage antiarthrose
EP0011471B1 (fr) *	1978-11-17	1983-02-09	SMITH & NEPHEW RESEARCH LIMITED	Matériau en feuille revêtu d'un adhésif dans lequel sont incorporées des substances bactéricides
FR2474865A1 (fr) *	1980-02-05	1981-08-07	Aubert Pierre	Procede de preparation (par deshydratation et micronisation de sediments marins) d'une poudre composee de boue marine naturelle. produits obtenus et leur utilisation a des fins therapeutiques et cosmetiques
JPS5728004A (en) *	1980-07-29	1982-02-15	Japan Synthetic Rubber Co Ltd	Preparation of skin plaster having antistenocardiac activity
FR2489689B1 (fr) *	1980-09-11	1986-03-07	Heitz Jean	Composition a base d'argile pour le traitement esthetique ou therapeutique par bains du corps humain
JPS5775913A (en) *	1980-10-27	1982-05-12	Shunichi Akazawa	Germanium releasing material
NZ199071A (en) *	1980-12-08	1984-05-31	Johnson & Johnson Prod Inc	Surgical dressing activated charcoal impregnated with anti-microbial agent
JPS57126408A (en) *	1981-01-28	1982-08-06	Kiyo Kondo	Cosmetic containing germanium
JPS58130054A (ja) *	1982-01-29	1983-08-03	株式会社アドバンス	イオントフオレ−ゼ用プラスタ−構造体
FR2539032A1 (fr) *	1983-01-07	1984-07-13	Heitz Jean	Bande a charge active formee d'argile verte et procede pour sa fabrication
JPS6060176A (ja) *	1983-09-14	1985-04-06	Nippon Shokubai Kagaku Kogyo Co Ltd	体表面冷却用貼付材
JPS60253442A (ja) *	1984-05-29	1985-12-14	株式会社　ハマダ医研	馬の運動器疾患治療法

1982
- 1982-07-16 HU HU822195A patent/HU184575B/hu unknown
1983
- 1983-07-07 IL IL69179A patent/IL69179A/xx unknown
- 1983-07-12 FR FR8311596A patent/FR2531862B1/fr not_active Expired
- 1983-07-12 DD DD83252992A patent/DD209967A5/de not_active IP Right Cessation
- 1983-07-14 BE BE0/211175A patent/BE897292A/fr not_active IP Right Cessation
- 1983-07-15 JP JP58502340A patent/JPH0811733B2/ja not_active Expired - Lifetime
- 1983-07-15 CA CA000432571A patent/CA1228540A/fr not_active Expired
- 1983-07-15 ES ES524139A patent/ES524139A0/es active Granted
- 1983-07-15 AU AU17756/83A patent/AU565141B2/en not_active Ceased
- 1983-07-15 NL NL8320207A patent/NL8320207A/nl unknown
- 1983-07-15 PL PL1983243031A patent/PL145842B1/pl unknown
- 1983-07-15 DE DE3390091A patent/DE3390091C1/de not_active Expired - Fee Related
- 1983-07-15 GB GB08406700A patent/GB2133287B/en not_active Expired
- 1983-07-15 WO PCT/HU1983/000040 patent/WO1984000298A1/fr not_active Ceased
- 1983-07-15 CH CH1358/84A patent/CH664896A5/de not_active IP Right Cessation
- 1983-07-15 DE DE83HU8300040D patent/DE3390091D2/de not_active Expired
- 1983-07-18 IT IT67774/83A patent/IT1193431B/it active
1984
- 1984-02-17 FI FI840661A patent/FI84430C/fi not_active IP Right Cessation
- 1984-02-29 SE SE8401113A patent/SE462198B/sv not_active IP Right Cessation
- 1984-02-29 DK DK149984A patent/DK163106C/da not_active IP Right Cessation
- 1984-03-15 SU SU843712365A patent/SU1489574A3/ru active
- 1984-03-15 US US06/589,894 patent/US4755384A/en not_active Expired - Fee Related
1988
- 1988-02-26 SG SG128/88A patent/SG12888G/en unknown
- 1988-06-09 HK HK444/88A patent/HK44488A/xx not_active IP Right Cessation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3729443A1 (de) *	1987-09-03	1989-03-16	Riess Ortrun	Quaddelsetzpflaster

Also Published As

Publication number	Publication date
SE462198B (sv)	1990-05-21
SE8401113L (sv)	1984-02-29
AU565141B2 (en)	1987-09-03
US4755384A (en)	1988-07-05
WO1984000298A1 (fr)	1984-02-02
FI840661A0 (fi)	1984-02-17
HK44488A (en)	1988-06-17
SU1489574A3 (ru)	1989-06-23
JPH0811733B2 (ja)	1996-02-07
PL243031A1 (en)	1984-09-24
GB8406700D0 (en)	1984-04-18
ES8504465A1 (es)	1985-05-01
IT8367774A0 (it)	1983-07-18
DK163106B (da)	1992-01-20
DK149984D0 (da)	1984-02-29
ES524139A0 (es)	1985-05-01
IL69179A (en)	1989-09-28
DE3390091D2 (en)	1984-06-14
SG12888G (en)	1988-07-08
HU184575B (en)	1984-09-28
FI84430C (fi)	1991-12-10
PL145842B1 (en)	1988-11-30
AU1775683A (en)	1984-02-08
IT1193431B (it)	1988-06-22
FI84430B (fi)	1991-08-30
GB2133287B (en)	1986-12-31
NL8320207A (nl)	1984-06-01
SE8401113D0 (sv)	1984-02-29
CH664896A5 (de)	1988-04-15
BE897292A (fr)	1983-11-03
IL69179A0 (en)	1983-11-30
GB2133287A (en)	1984-07-25
DK163106C (da)	1992-06-09
JPS59501265A (ja)	1984-07-19
CA1228540A (fr)	1987-10-27
DK149984A (da)	1984-03-16
FI840661L (fi)	1984-02-17
DE3390091C1 (de)	1993-03-18
FR2531862A1 (fr)	1984-02-24
FR2531862B1 (fr)	1988-01-15

Legal Events

Date	Code	Title	Description
1999-04-01	ENJ	Ceased due to non-payment of renewal fee

Publication	Publication Date	Title
DD209967A5 (de)	1984-05-30	Verfahren zur herstellung von an der haut befestigbaren, insbesondere muskelkrampfloesenden praeparaten
DE3785789T2 (de)	1993-12-16	Apparat zur Verabreichung von Medikamenten durch Iontophorese.
DE69220808T2 (de)	1998-01-02	Vorrichtung zur verabreichung von heilmitteln
DE69814917T2 (de)	2004-02-12	Transdermale therapeutische vorrichtung mit capsaicin und seinen analogen
DE68925030T2 (de)	1996-07-25	Molekültransport durch gewebe mit der verwendung von elektroporation.
DE1902227A1 (de)	1969-09-04	Arzneimittel zur psychotherapeutischen Anwendung und Verfahren zu seiner Herstellung
DE60031709T2 (de)	2007-06-28	Zusammensetzungen für die elektroporation
DE10034673C1 (de)	2002-04-25	Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung
DE69504207T2 (de)	1999-04-01	Ionophoretische vorrichtung zur transdermalen verabreichung von medikamenten undentsprechende wegwerfeinheit
DE2006696A1 (de)	1970-09-17	Pflaster oder Haftverband
EP2702984A1 (fr)	2014-03-05	Pansement avec agent actif pour le traitement de symptômes locaux
DE69205307T2 (de)	1996-05-15	Vorrichtung zum Behandeln von Akupunkturpunkten mittels elektrischen Feldern und Medikamentenionen.
AT389049B (de)	1989-10-10	Verfahren zur herstellung von an der unverletzten haut befestigbaren pharmazeutischen paeparaten, insbesondere von muskelkrampfloesenden und antirheumatischen praeparaten
DE4315866C1 (de)	1994-05-05	Äußerliche Zubereitungen zur Therapie von Hauterkrankungen mit Photosensibilisatoren
DE3717243A1 (de)	1987-12-10	Verfahren und vorrichtung zur steigerung persoenlicher leistungsfaehigkeit
DE3048154C2 (fr)	1992-03-19
DE2444652A1 (de)	1975-03-20	Mittel zur bekaempfung lokaler schmerzen
DE2551159A1 (de)	1977-05-18	Verfahren zum aktivieren von vorrichtungen zur therapeutischen einwirkung auf akupunkturpunkte u.dgl.
DE3319670A1 (de)	1984-12-13	Mittel zur beschleunigten transdermalen applikation von wirkstoffen und naehrstoffen
EP0413792B1 (fr)	1992-07-15	Produits contenant un sel de lithium et un facteur de necrose de tumeurs
DE3447572A1 (de)	1986-07-03	Mittel zur regenerierung und staerkung tierischer und menschlicher organismen koerpereigener abwehrkraefte und der haut sowie zu deren schutz aus aloe-wirkstoffen
AT504040A1 (de)	2008-02-15	Diclofenac-hältige zubereitung zur behandlung von verbrennungen
DE920438C (de)	1954-11-22	Verfahren zur Gewinnung hirnwirksamer Substanzen
DE102018115270B4 (de)	2022-07-14	Zubereitung als Gel und Pflaster zur topischen Behandlung von Haut- und/oder Nagelerkrankungen
EP0842424B1 (fr)	1999-11-03	Procede pour determiner l'efficacite et la tolerance d'une substance xenogenique administree a un organisme

DD209967A5 - Verfahren zur herstellung von an der haut befestigbaren, insbesondere muskelkrampfloesenden praeparaten - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (1)

Publications (1)

Family

ID=10958788

Family Applications (1)

Country Status (23)

Cited By (1)

Families Citing this family (17)

Family Cites Families (30)

Cited By (1)

Also Published As

Similar Documents

Legal Events